POST-EVENT REPORT
30 June - 1 July 2026 | Sands Expo & Convention Centre, Singapore

Message From The Organiser

We extend our heartfelt gratitude to all our partners for their unwavering support in making Cell & Gene Therapy World Asia and Oligonucleotides & Peptides World Asia 2026 an outstanding success! We are excited to present you with this post-conference report, which highlights the key achievements and insights from this year’s event.

This report provides a comprehensive overview of Cell & Gene Therapy World Asia and Oligonucleotides & Peptides World Asia 2026, helping our valued partners assess the ROI from their participation. Held on 30 June – 1 July 2026, the conferences ran concurrently and featured the prestigious Asia-Pacific Cell & Gene Therapy Excellence Awards 2026 and Asia-Pacific RNA Excellence Awards, recognising outstanding achievements in both the cell and gene therapy and RNA sectors.

Once again, we had the privilege of hosting world-renowned speakers, industry experts, and leaders from across the Asia-Pacific region, who shared their expertise on the evolving landscapes of cell and gene therapy innovation, as well as oligonucleotide and peptide-based therapeutics. Participants benefited from insightful discussions, practical case studies, and valuable networking opportunities tailored to the rapidly expanding advanced therapies sector in APAC.

We are truly grateful for the positive feedback received, which reaffirmed the event’s relevance, balanced focus across both industries, and value in fostering meaningful connections that contribute to the continued growth and success of the industry.

As we reflect on this year’s success, we are excited to incorporate your feedback and suggestions to make the 2027 edition even bigger and better.

We look forward to welcoming you back on 23 - 24 March 2027 as Cell & Gene Therapy World Asia and Oligonucleotides & Peptides World Asia will be co-located at APAC Biopharma Confex 2027.

APAC Biopharma Confex 2027 will feature co-located events including Biologics Manufacturing Asia, Clinical Trials Festival Asia, ADC Asia Congress, and BioSupply Chain Asia. The Biopharma Confex serves as a central meeting place for the Asia's biopharma ecosystem, supporting collaboration, knowledge sharing, innovation, and strategic partnerships across Asia-Pacific.

Once again, thank you for your continued partnership and for contributing to the growth and success of the industry. We look forward to seeing you next year.

Warm regards, The IMAPAC Team

We extend our heartfelt gratitude to all our partners for their unwavering support in making Cell & Gene Therapy World Asia and Oligonucleotides & Peptides World Asia 2026 an outstanding success! We are excited to present you with this post-conference report, which highlights the key achievements and insights from this year’s event.

This report provides a comprehensive overview of Cell & Gene Therapy World Asia and Oligonucleotides & Peptides World Asia 2026, helping our valued partners assess the ROI from their participation. Held on 30 June – 1 July 2026, the conferences ran concurrently and featured the prestigious Asia-Pacific Cell & Gene Therapy Excellence Awards 2026 and Asia-Pacific RNA Excellence Awards, recognising outstanding achievements in both the cell and gene therapy and RNA sectors.

Once again, we had the privilege of hosting world-renowned speakers, industry experts, and leaders from across the Asia-Pacific region, who shared their expertise on the evolving landscapes of cell and gene therapy innovation, as well as oligonucleotide and peptide-based therapeutics. Participants benefited from insightful discussions, practical case studies, and valuable networking opportunities tailored to the rapidly expanding advanced therapies sector in APAC.

We are truly grateful for the positive feedback received, which reaffirmed the event’s relevance, balanced focus across both industries, and value in fostering meaningful connections that contribute to the continued growth and success of the industry.

As we reflect on this year’s success, we are excited to incorporate your feedback and suggestions to make the 2027 edition even bigger and better.

We look forward to welcoming you back on 23 - 24 March 2027 as Cell & Gene Therapy World Asia and Oligonucleotides & Peptides World Asia will be co-located at APAC Biopharma Confex 2027.

APAC Biopharma Confex 2027 will feature co-located events including Biologics Manufacturing Asia, Clinical Trials Festival Asia, ADC Asia Congress, and BioSupply Chain Asia. The Biopharma Confex serves as a central meeting place for the Asia's biopharma ecosystem, supporting collaboration, knowledge sharing, innovation, and strategic partnerships across Asia-Pacific.

Once again, thank you for your continued partnership and for contributing to the growth and success of the industry. We look forward to seeing you next year.

Warm regards, The IMAPAC Team

Attendee Breakdown

Attendees

Companies

Speakers

Testimonials